Red wine may ward off lung cancer: study

Key points
- Drinking red wine, but not white wine, may reduce lung cancer risk, especially among current and ex-smokers, new research indicates.
- People who had ever smoked and who drank at least a glass of red wine daily were 60 percent less like to develop lung cancer than ever-smokers who didn't drink alcohol, Dr.
- But white wine didn't reduce risk, suggesting it could be compounds contained in red wine, such as resveratrol and flavonoids, rather than the healthier lifestyle associated with wine drinking, that may be protective, the researchers say.
- Studies examining the relationship between lung cancer and alcohol consumption have had mixed results, they note in the journal Cancer Epidemiology, Biomarkers and Prevention.
Drinking red wine, but not white wine, may reduce lung cancer risk, especially among current and ex-smokers, new research indicates.
People who had ever smoked and who drank at least a glass of red wine daily were 60 percent less like to develop lung cancer than ever-smokers who didn't drink alcohol, Dr. Chun Chao of Kaiser Permanente Southern California in Pasadena and colleagues found.
But white wine didn't reduce risk, suggesting it could be compounds contained in red wine, such as resveratrol and flavonoids, rather than the healthier lifestyle associated with wine drinking, that may be protective, the researchers say.
Studies examining the relationship between lung cancer and alcohol consumption have had mixed results, they note in the journal Cancer Epidemiology, Biomarkers and Prevention. Much of this research has failed to adjust for factors like socioeconomic status that can influence both alcohol use and lung cancer risk.
In the current study, Chao and her colleagues looked at 84,170 men 45 to 69 years old covered by Kaiser Permanente California health plans. Between 2000 and 2006, 210 of them developed lung cancer.
After accounting for the influence of age, education, income, exposure to second-hand smoke, body weight, and other relevant factors, the researchers found that lung cancer risk steadily decreased with red wine drinking, with a 2 percent drop seen with each additional glass of red wine a man drank per month. No other type of alcoholic beverage, including white wine, was associated with lung cancer risk.
For men who were heavy smokers, the reduction in risk was greater, with a 4 percent lower likelihood of developing lung cancer seen for each glass of red wine consumed per month.
Research has shown that wine drinkers may have healthier lifestyles and tend to have more education and higher income than non-wine drinkers, the researchers note. But the fact that reduced lung cancer risk was seen only with red wine, not white, "lends support to a causal association for red wine and suggests that compounds that are present at high concentrations in red wine but not in white wine, beer or liquors may be protective against lung carcinogenesis," Chao and her team say.
SOURCE: Cancer Epidemiology, Biomarkers and Prevention, October 2008.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsLocal treatment of lung cancer
Nanoparticles are extremely small particles that can be modified for a variety of uses in the medical field. For example, nanoparticles can be engineered to be able to transport medicines specifically to the disease…
6 March 2015
NewsStudy suggests need for more sensitive lung cancer screening criteria
An analysis of lung cancer incidence and screening found a decline in the proportion of patients with lung cancer meeting high-risk screening criteria, suggesting that an increasing number of patients with lung cancer…
25 February 2015
NewsDecline in smoking rates may increase lung cancer mortality
A decline in smoking rates may mean that many people who could have benefited from early detection of lung cancer are dying because they don't qualify for low-dose CT scans, according to a group of Mayo Clinic…
25 February 2015


